Background: Vagally mediated syncope and functional bradyarrhythmias can cause recurrent symptoms, injury and a need for permanent pacing, yet standard therapies do not address the underlying autonomic reflex. Cardioneuroablation (CNA) targets this mechanism, but adoption has been limited by uncertainty about patient selection, procedural endpoints and durable outcomes. Methods: We studied 95 consecutive patients with vagally mediated syncope (n=78) or functional bradyarrhythmia (n=17) who underwent CNA at a single center by a single lead operator under a uniform, prospectively maintained prot
Physiology-guided cardioneuroablation for vagally mediated syncope and functional bradyarrhythmias
calendar_today
August 5, 2026
person
Kowlgi, G. N., Pachon-M, J. C., Prasitlumkum, N., Gulati, A., Yoo, J., Karlen, K., Tan, N. Y. L., Sugrue, A., Killu, A. M., Deshmukh, A., Kapa, S., DeSimone, C. V., Del-Carpio Munoz, F., Siontis, K. C., Madhavan, M., Noseworthy, P. A., Friedman, P. A., Pachon-Mateos, E., Pachon, C., Zerpa, J., Cha, Y.-M., Shen, W.-K., Asirvatham, S. J.
domain
medrxiv